Skip to main content
logo
GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India flag India · Delayed Price · Currency is INR
2,274.05
+4.25 (0.19%)
At close: Jan 21, 2026

BOM:500660 Revenue

GlaxoSmithKline Pharmaceuticals had revenue of 9.80B INR in the quarter ending September 30, 2025, a decrease of -3.05%. This brings the company's revenue in the last twelve months to 37.09B, up 4.17% year-over-year. In the fiscal year ending March 31, 2025, GlaxoSmithKline Pharmaceuticals had annual revenue of 37.49B with 8.56% growth.

Revenue (ttm)
37.09B
Revenue Growth
+4.17%
P/S Ratio
10.87
Revenue / Employee
11.91M
Employees
3,113
Market Cap
403.16B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202537.49B2.96B8.56%
Mar 31, 202434.54B2.02B6.21%
Mar 31, 202332.52B-263.06M-0.80%
Mar 31, 202232.78B3.52B12.05%
Mar 31, 202129.26B-2.99B-9.27%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Dr. Reddy's Laboratories345.83B
Lupin247.51B
Torrent Pharmaceuticals122.48B
Jubilant Pharmova76.18B
Abbott India67.14B
Granules India48.42B
J. B. Chemicals & Pharmaceuticals41.93B
Caplin Point Laboratories20.42B
Revenue Rankings

GlaxoSmithKline Pharmaceuticals News

More News